MCID: HMP009
MIFTS: 43

Haemophilus Influenzae

Categories: Infectious diseases, Rare diseases

Aliases & Classifications for Haemophilus Influenzae

Summaries for Haemophilus Influenzae

MalaCards based summary : Haemophilus Influenzae, also known as h. influenzae, is related to epiglottitis and bacterial meningitis. An important gene associated with Haemophilus Influenzae is LACTB (Lactamase Beta), and among its related pathways/superpathways are IL-17 Family Signaling Pathways and Salmonella infection (KEGG). The drugs Temocillin and Prednisolone phosphate have been mentioned in the context of this disorder. Affiliated tissues include testes, colon and lung, and related phenotype is homeostasis/metabolism.

Wikipedia : 74 Haemophilus influenzae (formerly called Pfeiffer's bacillus or Bacillus influenzae) is a Gram-negative,... more...

Related Diseases for Haemophilus Influenzae

Diseases related to Haemophilus Influenzae via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 578, show less)
# Related Disease Score Top Affiliating Genes
1 epiglottitis 33.4 OMP LACTB
2 bacterial meningitis 32.4 TNF TLR2 LACTB CXCL8
3 meningitis 31.5 TNF TLR2 LACTB CXCL8
4 otitis media 31.4 TNF TLR2 LACTB CXCL8
5 septic arthritis 31.1 TNF TLR2 CXCL8
6 pneumonia 31.0 VTN TNF TLR2 LACTB CXCL8
7 bronchitis 30.9 TNF TLR2 LTF LACTB CXCL8
8 pericarditis 30.9 VTN TNF CXCL8
9 osteomyelitis 30.8 TNF TLR2 CXCL8
10 neisseria meningitidis infection 30.8 TLR2 OMP LACTB
11 bronchopneumonia 30.7 TNF CXCL8
12 bronchiectasis 30.7 TNF TLR2 CXCL8
13 lung abscess 30.7 TNF LACTB
14 measles 30.7 TNF TLR2 CXCL8
15 salpingitis 30.6 TNF TLR2
16 peritonitis 30.5 TNF TLR2 CXCL8
17 endophthalmitis 30.5 TNF TLR2 CXCL8
18 toxic shock syndrome 30.5 TNF TLR2 CXCL8
19 acute cystitis 30.5 TNF TLR2 CXCL8
20 endocarditis 30.5 TNF TLR2 LACTB CXCL8
21 urethritis 30.4 TNF TLR2 CXCL8
22 pharyngitis 30.4 TNF LACTB CXCL8
23 tonsillitis 30.3 TNF TLR2 LACTB CXCL8
24 meningococcal meningitis 30.3 TLR2 CFH
25 bacterial infectious disease 30.3 TNF TLR2 LTF CXCL8
26 bacterial pneumonia 30.2 TNF TLR2 LACTB CXCL8
27 vaginitis 30.2 TNF TLR2 CXCL8
28 streptococcus pneumonia 30.2 TNF TLR2 CXCL8
29 gastroenteritis 30.2 TNF LACTB CXCL8
30 middle ear disease 30.1 TNF TLR2 CXCL8
31 bacterial sepsis 30.1 TNF TLR2 CXCL8
32 aspiration pneumonitis 30.1 TNF CXCL8
33 pustulosis of palm and sole 30.1 TNF CXCL8
34 chlamydia 30.0 TNF TLR2 CXCL8
35 vaginal discharge 30.0 TNF CXCL8
36 common cold 30.0 TNF TLR2 CXCL8
37 bronchiolitis 30.0 TNF TLR2 CXCL8
38 cystic fibrosis 29.9 TNF TLR2 LTF CXCL8
39 preterm premature rupture of the membranes 29.9 TNF TLR2 CXCL8
40 endometritis 29.8 TNF TLR2 LACTB CXCL8
41 deficiency anemia 29.8 TNF TF LTF
42 chlamydia pneumonia 29.7 TNF TLR2 CXCL8
43 periodontitis 29.7 TNF TLR2 CXCL8
44 cervicitis 29.7 TNF TLR2 CXCL8
45 aphthous stomatitis 29.7 TNF TLR2 CXCL8
46 proteasome-associated autoinflammatory syndrome 1 29.6 TNF TLR2 CXCL8
47 chronic mucocutaneous candidiasis 29.6 TNF TLR2 CLEC7A
48 alcoholic hepatitis 29.6 TNF TLR2 CXCL8
49 food allergy 29.6 TNF TLR2 CXCL8
50 gout 29.6 TNF TLR2 CXCL8
51 tuberculous meningitis 29.5 TNF TLR2 CXCL8
52 candidiasis 29.3 TNF TLR2 CXCL8 CLEC7A
53 reactive arthritis 29.2 TNF TLR2 OMP LTF CXCL8
54 thrombocytopenia 28.9 TNF TLR2 CXCL8 CFH
55 asthma 28.6 VTN TNF TLR2 TF CXCL8
56 haemophilus meningitis 12.0
57 guillain-barre syndrome 11.8
58 complement component 3 deficiency, autosomal recessive 11.4
59 specific antibody deficiency 11.4
60 immunodeficiency 33 11.4
61 tetanus 11.2
62 diphtheria 11.2
63 pertussis 11.1
64 pulmonary disease, chronic obstructive 10.9
65 cellulitis 10.9
66 poliomyelitis 10.9
67 breast-ovarian cancer, familial 2 10.9
68 conjunctivitis 10.8
69 lung disease 10.7
70 influenza 10.6
71 pleural empyema 10.6
72 rubella 10.6
73 mumps 10.5
74 cholera 10.5
75 arthritis 10.5
76 purpura 10.5
77 48,xyyy 10.5
78 hepatitis a 10.4
79 pneumococcal meningitis 10.4
80 branchiootic syndrome 1 10.4
81 fasciitis 10.4
82 immune deficiency disease 10.4
83 necrotizing fasciitis 10.4
84 47,xyy 10.4
85 sickle cell disease 10.4
86 mycobacterium fortuitum 10.4 LACTB CXCL8
87 mulchandani-bhoj-conlin syndrome 10.4
88 chorioamnionitis 10.4
89 bacterial conjunctivitis 10.4
90 ocular motor apraxia 10.4
91 agammaglobulinemia 10.4
92 chickenpox 10.4
93 leukemia, acute lymphoblastic 3 10.4
94 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.4
95 hydrocephalus 10.4
96 waterhouse-friderichsen syndrome 10.4
97 purpura fulminans 10.3
98 orbital cellulitis 10.3
99 aortic aneurysm 10.3
100 aneurysm 10.3
101 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
102 infective endocarditis 10.3
103 sensorineural hearing loss 10.3
104 common variable immunodeficiency 10.3
105 neutropenia 10.3
106 hepatitis b 10.3
107 cytokine deficiency 10.3
108 primary agammaglobulinemia 10.3
109 seizure disorder 10.3
110 mycobacterium chelonae 10.3 TLR2 CXCL8
111 mycobacterium marinum 10.3 TLR2 CXCL8
112 mycobacterium kansasii 10.3 TLR2 CXCL8
113 ige responsiveness, atopic 10.3
114 down syndrome 10.3
115 autosomal recessive cerebellar ataxia 10.3
116 respiratory failure 10.3
117 disseminated intravascular coagulation 10.3
118 pyelonephritis 10.3
119 rhinitis 10.3
120 meningococcal infection 10.3
121 argyria 10.3
122 neurosyphilis 10.3 TLR2 CXCL8
123 nocardiosis 10.2 TNF LACTB
124 idiopathic anterior uveitis 10.2 TNF CXCL8
125 keratitis, hereditary 10.2
126 sickle cell anemia 10.2
127 helix syndrome 10.2
128 mastoiditis 10.2
129 meningoencephalitis 10.2
130 acute conjunctivitis 10.2
131 cardiac tamponade 10.2
132 suppurative otitis media 10.2
133 acquired immunodeficiency syndrome 10.2
134 streptococcal toxic-shock syndrome 10.2 TNF CXCL8
135 toxicodendron dermatitis 10.2 TNF CXCL8
136 cardiac rupture 10.2 TNF CXCL8
137 transverse myelitis 10.2 TNF CXCL8
138 fibrosis of extraocular muscles, congenital, 1 10.2
139 myositis 10.2
140 triiodothyronine receptor auxiliary protein 10.2
141 myeloma, multiple 10.2
142 sudden infant death syndrome 10.2
143 human immunodeficiency virus type 1 10.2
144 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.2
145 aseptic meningitis 10.2
146 cholecystitis 10.2
147 vulvovaginitis 10.2
148 congestive heart failure 10.2
149 corneal ulcer 10.2
150 primary ciliary dyskinesia 10.2
151 tenosynovitis 10.2
152 overgrowth syndrome 10.2
153 denture stomatitis 10.2 CXCL8 CLEC7A
154 progressive myoclonus epilepsy 8 10.2 TNF CXCL8
155 eales disease 10.2 TNF TF
156 peptic esophagitis 10.2 TNF CXCL8
157 irritant dermatitis 10.2 TNF CXCL8
158 sapho syndrome 10.2 TNF CXCL8
159 cryptogenic organizing pneumonia 10.2 TNF CXCL8
160 superficial siderosis of the central nervous system 10.1 TF LTF
161 superficial siderosis 10.1 TF LTF
162 clonorchiasis 10.1 TNF CXCL8
163 pouchitis 10.1 LTF CXCL8
164 cardiomyopathy, familial hypertrophic, 20 10.1 TNF CXCL8
165 trichomoniasis 10.1 TNF CXCL8
166 funisitis 10.1 TNF CXCL8
167 fungal keratitis 10.1 TLR2 CLEC7A
168 nontuberculous mycobacterial lung disease 10.1 TNF TLR2
169 congenital cytomegalovirus 10.1 TNF TLR2
170 aortic aneurysm, familial abdominal, 1 10.1
171 autoimmune disease 10.1
172 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.1
173 ataxia and polyneuropathy, adult-onset 10.1
174 allergic rhinitis 10.1
175 bacteremia 1 10.1
176 bacteremia 2 10.1
177 adenoiditis 10.1
178 exanthem 10.1
179 thalassemia 10.1
180 hypopyon 10.1
181 erysipelas 10.1
182 hemopericardium 10.1
183 dysgammaglobulinemia 10.1
184 pericardial effusion 10.1
185 diarrhea 10.1
186 pleuropneumonia 10.1
187 prostatitis 10.1
188 ventricular septal defect 10.1
189 heart septal defect 10.1
190 thrombocytosis 10.1
191 orchitis 10.1
192 dermatitis 10.1
193 hemoglobinopathy 10.1
194 teratoma 10.1
195 cerebritis 10.1
196 shwartzman phenomenon 10.1
197 brain edema 10.1
198 kidney disease 10.1
199 pyosalpinx 10.1
200 mediastinitis 10.1
201 pyomyositis 10.1
202 croup 10.1
203 encephalitis 10.1
204 neonatal meningitis 10.1
205 back pain 10.1
206 febrile seizures 10.1
207 headache 10.1
208 chronic conjunctivitis 10.1 TNF CXCL8
209 cardiac sarcoidosis 10.1 TNF CXCL8
210 spondylarthropathy 10.1 TNF TLR2
211 superficial basal cell carcinoma 10.1 TNF TLR2
212 trichuriasis 10.1 TNF CXCL8
213 melancholia 10.1 TNF TF
214 pneumonic tularemia 10.1 TNF TLR2
215 tularemia 10.1 TNF TLR2
216 pneumonic plague 10.1 TNF TLR2
217 ophthalmia nodosa 10.1 TF LTF
218 opisthorchiasis 10.1 TNF CXCL8
219 viral pneumonia 10.1 TNF CXCL8
220 papillary conjunctivitis 10.1 LTF CXCL8
221 giant papillary conjunctivitis 10.1 LTF CXCL8
222 vitreous disease 10.1 TNF CXCL8
223 burning mouth syndrome 10.0 TNF CXCL8
224 blastomycosis 10.0 TNF CLEC7A
225 cecal disease 10.0 TNF CXCL8
226 alcohol dependence 10.0
227 multiple sclerosis 10.0
228 systemic lupus erythematosus 10.0
229 sarcoidosis 1 10.0
230 thymoma, familial 10.0
231 agammaglobulinemia, x-linked 10.0
232 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
233 leukemia, acute lymphoblastic 10.0
234 beta-thalassemia 10.0
235 graft-versus-host disease 10.0
236 immunoglobulin alpha deficiency 10.0
237 adenoid hypertrophy 10.0
238 pollen allergy 10.0
239 pelvic inflammatory disease 10.0
240 cholelithiasis 10.0
241 purulent acute otitis media 10.0
242 nasopharyngitis 10.0
243 rickets 10.0
244 frontal sinusitis 10.0
245 acute salpingitis 10.0
246 prostatic hypertrophy 10.0
247 subdural empyema 10.0
248 visual epilepsy 10.0
249 polyneuropathy 10.0
250 labyrinthitis 10.0
251 urticaria 10.0
252 cerebral palsy 10.0
253 iron metabolism disease 10.0
254 thymoma 10.0
255 subacute bacterial endocarditis 10.0
256 aortitis 10.0
257 hemolytic anemia 10.0
258 severe combined immunodeficiency 10.0
259 thyroiditis 10.0
260 end stage renal disease 10.0
261 herpes simplex 10.0
262 lupus erythematosus 10.0
263 tracheitis 10.0
264 epididymo-orchitis 10.0
265 allergic asthma 10.0
266 pulmonary emphysema 10.0
267 hypereosinophilic syndrome 10.0
268 chronic graft versus host disease 10.0
269 congenital extrahepatic portosystemic shunt 10.0
270 mollaret meningitis 10.0
271 splenomegaly 10.0
272 dysphagia 10.0
273 head injury 10.0
274 periapical granuloma 10.0 TLR2 CXCL8
275 meconium aspiration syndrome 10.0 TNF CXCL8
276 felty syndrome 10.0 LTF CXCL8
277 alveolar echinococcosis 10.0 TNF TLR2
278 pleural tuberculosis 10.0 TNF CXCL8
279 macular retinal edema 10.0 TNF CXCL8
280 rheumatoid vasculitis 10.0 TNF LTF
281 coccidioidomycosis 10.0 TNF CLEC7A
282 pneumocystosis 9.9 TNF CLEC7A
283 salmonellosis 9.9 TNF TLR2 LACTB
284 colitis 9.9 TNF TLR2 CXCL8
285 periapical periodontitis 9.9 TNF TLR2 CXCL8
286 dental pulp disease 9.9 TNF TLR2 CXCL8
287 dermatophytosis 9.9 LTF CLEC7A
288 blood group, globoside system 9.9 TNF TLR2 CXCL8
289 endometrial disease 9.9 TNF TLR2 CXCL8
290 pyelitis 9.9 TNF TLR2 CXCL8
291 lichen disease 9.9 TNF CXCL8
292 amebiasis 9.9 TNF TLR2 CXCL8
293 fallopian tube disease 9.9 TNF TLR2 CXCL8
294 gingival disease 9.9 TNF TLR2 CXCL8
295 rosacea 9.9 TNF TLR2 CXCL8
296 endocardium disease 9.9 TNF TLR2 CXCL8
297 sebaceous gland disease 9.9 TNF TLR2 CXCL8
298 coccidiosis 9.9 TNF TLR2 CXCL8
299 conjunctival disease 9.9 TNF TLR2 CXCL8
300 anus disease 9.9 TNF TLR2 CXCL8
301 pleurisy 9.9 TNF TLR2 CXCL8
302 leptospirosis 9.9 TNF TLR2 CXCL8
303 invasive aspergillosis 9.9 TLR2 CXCL8 CLEC7A
304 rectal disease 9.9 TNF TLR2 CXCL8
305 leukemia, acute monocytic 9.9 TNF TLR2 CXCL8
306 nasal cavity disease 9.9 TNF TLR2 CXCL8
307 aggressive periodontitis 9.9 TNF TLR2 CXCL8
308 hypersensitivity reaction type iv disease 9.9 TNF TLR2 CXCL8
309 nose disease 9.9 TNF TLR2 CXCL8
310 bronchiolitis obliterans 9.9 TNF TLR2 CXCL8
311 commensal bacterial infectious disease 9.9 TNF TLR2 CXCL8
312 legionellosis 9.9 TNF TLR2 CXCL8
313 contact dermatitis 9.9 TNF TLR2 CXCL8
314 cutaneous leishmaniasis 9.9 TNF TLR2 CXCL8
315 leishmaniasis 9.9 TNF TLR2 CXCL8
316 leprosy 3 9.9 TNF TLR2 CXCL8
317 visceral leishmaniasis 9.9 TNF TLR2 CXCL8
318 alcoholic liver cirrhosis 9.9 TNF TLR2 CXCL8
319 familial mediterranean fever 9.9 TNF TLR2 CXCL8
320 lichen planus 9.9 TNF TLR2 CXCL8
321 hyper ige syndrome 9.9 TNF TLR2 CXCL8
322 irritable bowel syndrome 9.9 TNF TLR2 CXCL8
323 parasitic protozoa infectious disease 9.9 TNF TLR2 CXCL8
324 apert syndrome 9.9
325 amyotrophic lateral sclerosis 1 9.9
326 aortic valve disease 1 9.9
327 cleft palate, isolated 9.9
328 ear malformation 9.9
329 attention deficit-hyperactivity disorder 9.9
330 kaposi sarcoma 9.9
331 legg-calve-perthes disease 9.9
332 neutrophil migration 9.9
333 pulmonary fibrosis, idiopathic 9.9
334 schistosoma mansoni infection, susceptibility/ 9.9
335 strabismus 9.9
336 testicular torsion 9.9
337 thrombocytopenia 2 9.9
338 thrombocytopenic purpura, autoimmune 9.9
339 thrombophilia due to thrombin defect 9.9
340 vitreoretinopathy, neovascular inflammatory 9.9
341 complement component 2 deficiency 9.9
342 cystic disease of lung 9.9
343 brittle cornea syndrome 1 9.9
344 hydrocephalus, congenital, 1 9.9
345 papilloma of choroid plexus 9.9
346 wiskott-aldrich syndrome 9.9
347 kearns-sayre syndrome 9.9
348 prostatic hyperplasia, benign 9.9
349 yemenite deaf-blind hypopigmentation syndrome 9.9
350 convulsions, familial infantile, with paroxysmal choreoathetosis 9.9
351 dermatitis, atopic 9.9
352 orthostatic intolerance 9.9
353 panbronchiolitis, diffuse 9.9
354 langerhans cell histiocytosis 9.9
355 pars planitis 9.9
356 spastic paraplegia, ataxia, and mental retardation 9.9
357 hypertensive nephropathy 9.9
358 ovarian hyperstimulation syndrome 9.9
359 microphthalmia, syndromic 10 9.9
360 kawasaki disease 9.9
361 diabetes mellitus, ketosis-prone 9.9
362 microvascular complications of diabetes 3 9.9
363 microvascular complications of diabetes 4 9.9
364 microvascular complications of diabetes 6 9.9
365 microvascular complications of diabetes 7 9.9
366 retinitis pigmentosa 48 9.9
367 cyanosis, transient neonatal 9.9
368 mannose-binding lectin deficiency 9.9
369 hyperprolactinemia 9.9
370 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.9
371 variola major 9.9
372 paralytic poliomyelitis 9.9
373 marginal zone b-cell lymphoma 9.9
374 secondary progressive multiple sclerosis 9.9
375 sleep apnea 9.9
376 pervasive developmental disorder 9.9
377 stuttering 9.9
378 uvulitis 9.9
379 cardiac arrest 9.9
380 myelomeningocele 9.9
381 dextro-looped transposition of the great arteries 9.9
382 childhood acute lymphocytic leukemia 9.9
383 nodal marginal zone lymphoma 9.9
384 hereditary mixed polyposis syndrome 9.9
385 intracranial abscess 9.9
386 parotitis 9.9
387 viral meningitis 9.9
388 meningocele 9.9
389 herpangina 9.9
390 hemiplegia 9.9
391 discitis 9.9
392 rabies 9.9
393 adult respiratory distress syndrome 9.9
394 recurrent corneal erosion 9.9
395 chondrocalcinosis 9.9
396 streptococcal meningitis 9.9
397 blind hypotensive eye 9.9
398 cortical blindness 9.9
399 nephrotic syndrome 9.9
400 allergic hypersensitivity disease 9.9
401 plica syndrome 9.9
402 leukemia 9.9
403 acute leukemia 9.9
404 quadriplegia 9.9
405 miller fisher syndrome 9.9
406 hereditary spherocytosis 9.9
407 typhoid fever 9.9
408 diamond-blackfan anemia 9.9
409 pure red-cell aplasia 9.9
410 pulmonary sarcoidosis 9.9
411 scleritis 9.9
412 urethral syndrome 9.9
413 tetanus neonatorum 9.9
414 obstructive jaundice 9.9
415 biliary atresia 9.9
416 panophthalmitis 9.9
417 multiple cranial nerve palsy 9.9
418 squamous cell papilloma 9.9
419 facial paralysis 9.9
420 schistosomiasis 9.9
421 bacteriuria 9.9
422 chronic purulent otitis media 9.9
423 gonadal dysgenesis 9.9
424 reye syndrome 9.9
425 glossitis 9.9
426 angioedema 9.9
427 communicating hydrocephalus 9.9
428 rheumatic fever 9.9
429 lymphadenitis 9.9
430 pneumothorax 9.9
431 duodenal ulcer 9.9
432 vascular disease 9.9
433 rectum cancer 9.9
434 acute maxillary sinusitis 9.9
435 maxillary sinusitis 9.9
436 transient arthritis 9.9
437 hepatitis 9.9
438 keratopathy 9.9
439 lateral sclerosis 9.9
440 neonatal jaundice 9.9
441 papilloma 9.9
442 synovitis 9.9
443 auditory system disease 9.9
444 prostatic adenoma 9.9
445 pulmonary tuberculosis 9.9
446 anuria 9.9
447 iga glomerulonephritis 9.9
448 adenocarcinoma 9.9
449 substance abuse 9.9
450 acute kidney failure 9.9
451 paratyphoid fever 9.9
452 neurilemmoma 9.9
453 demyelinating disease 9.9
454 vaccinia 9.9
455 histiocytosis 9.9
456 laryngitis 9.9
457 plague 9.9
458 turner syndrome 9.9
459 protein c deficiency 9.9
460 pulmonary fibrosis 9.9
461 cranial nerve palsy 9.9
462 pituitary adenoma 9.9
463 thrombophlebitis 9.9
464 syphilis 9.9
465 polyradiculoneuropathy 9.9
466 mucoepidermoid carcinoma 9.9
467 ludwig's angina 9.9
468 cervical adenitis 9.9
469 liver cirrhosis 9.9
470 demyelinating polyneuropathy 9.9
471 mature teratoma 9.9
472 acute pyelonephritis 9.9
473 lymphopenia 9.9
474 acute disseminated encephalomyelitis 9.9
475 axonal neuropathy 9.9
476 acute endometritis 9.9
477 childhood leukemia 9.9
478 chronic kidney disease 9.9
479 appendicitis 9.9
480 osteoarthritis 9.9
481 hodgkin's lymphoma, lymphocytic-histiocytic predominance 9.9
482 vasculitis 9.9
483 smallpox 9.9
484 psoriasis 9.9
485 learning disability 9.9
486 gas gangrene 9.9
487 mechanical strabismus 9.9
488 keratoconjunctivitis 9.9
489 cholangitis 9.9
490 exposure keratitis 9.9
491 dacryoadenitis 9.9
492 ethmoid sinusitis 9.9
493 placental abruption 9.9
494 cervical incompetence 9.9
495 ophthalmia neonatorum 9.9
496 central corneal ulcer 9.9
497 dacryocystitis 9.9
498 heterotaxy 9.9
499 ankrd26-related thrombocytopenia 9.9
500 trichorhinophalangeal syndrome 9.9
501 bronchogenic cyst 9.9
502 cerebrospinal fluid leak 9.9
503 chromosomal triplication 9.9
504 encephalocele 9.9
505 meningococcemia 9.9
506 ring chromosome 2 9.9
507 urachal cyst 9.9
508 autonomic dysfunction 9.9
509 cytomegalovirus infection 9.9
510 encephalopathy 9.9
511 hypotonia 9.9
512 tremor 9.9
513 atopic keratoconjunctivitis 9.9
514 rapidly involuting congenital hemangioma 9.9
515 idiopathic bronchiectasis 9.9
516 parenteral nutrition-associated cholestasis 9.9
517 acute motor axonal neuropathy 9.9
518 acute motor and sensory axonal neuropathy 9.9
519 vitreoretinopathy 9.9
520 red cell aplasia 9.9
521 precursor t-cell acute lymphoblastic leukemia 9.9
522 drug-induced lupus erythematosus 9.9 TNF CXCL8
523 corneal disease 9.9 TNF TLR2 CXCL8
524 autoimmune disease of musculoskeletal system 9.9 TNF TLR2 CXCL8
525 multifocal choroiditis 9.9 TNF CFH
526 choroiditis 9.9 TNF CFH
527 bronchial disease 9.9 TNF TLR2 CXCL8
528 primary bacterial infectious disease 9.9 TNF TLR2 CXCL8
529 non-alcoholic steatohepatitis 9.9 TNF TLR2 CXCL8
530 trypanosomiasis 9.9 TNF TLR2 CXCL8
531 autoimmune disease of central nervous system 9.9 TNF TLR2 CXCL8
532 chagas disease 9.9 TNF TLR2 CXCL8
533 bone inflammation disease 9.9 TNF TLR2 CXCL8
534 integumentary system disease 9.8 TNF TLR2 CXCL8
535 upper respiratory tract disease 9.8 TNF TLR2 CXCL8
536 louse-borne relapsing fever 9.8 TNF CFH
537 relapsing fever 9.8 TNF CFH
538 crohn's disease 9.8 TNF TLR2 CXCL8
539 mastitis 9.8 TLR2 LTF CXCL8
540 primary systemic mycosis 9.8 TNF TLR2 CLEC7A
541 oral candidiasis 9.8 LTF CXCL8 CLEC7A
542 radiation proctitis 9.8 TNF TF LTF
543 shigellosis 9.8 TNF LTF CXCL8
544 behcet syndrome 9.8 TNF TLR2 CXCL8
545 pulpitis 9.7 TNF CXCL8
546 keratoconjunctivitis sicca 9.7 TNF LTF
547 viral infectious disease 9.7 TNF TLR2 CXCL8
548 iron deficiency anemia 9.7 TNF TF LTF
549 purulent labyrinthitis 9.7
550 hemangioma 9.7
551 acute interstitial pneumonia 9.7
552 herpes zoster 9.7
553 celiac disease 1 9.7 TNF TLR2 CXCL8
554 blepharitis 9.7 TNF LTF
555 gastritis 9.7 TNF LTF CXCL8
556 chronic granulomatous disease 9.7 TNF LTF CXCL8
557 mycobacterium tuberculosis 1 9.7 TNF TLR2 CLEC7A
558 interstitial lung disease 9.7 VTN TNF TF CXCL8
559 dysentery 9.6 TNF TLR2 TF CXCL8
560 crohn's colitis 9.6 TNF CXCL8
561 skin disease 9.5 VTN TNF TLR2 CXCL8
562 autosomal genetic disease 9.5 TNF CXCL8 CFH
563 mycobacterium abscessus 9.5 TNF TLR2 CXCL8 CLEC7A
564 vaginal disease 9.5 TNF TLR2 CXCL8 CLEC7A
565 opportunistic mycosis 9.5 TNF TLR2 CXCL8 CLEC7A
566 fungal infectious disease 9.5 TNF TLR2 CXCL8 CLEC7A
567 lyme disease 9.5 TNF TLR2 CFH
568 aspergillosis 9.5 TNF TLR2 CXCL8 CLEC7A
569 histoplasmosis 9.5 TNF CLEC7A CFH
570 peripheral nervous system disease 9.5 TNF TLR2 CXCL8
571 perinatal necrotizing enterocolitis 9.5 TNF TLR2 LTF CXCL8
572 bacterial vaginosis 9.5 TNF TLR2 LTF CXCL8
573 gingivitis 9.4 TNF TLR2 LTF CXCL8
574 eye disease 9.2 TNF TLR2 CXCL8 CFH
575 diabetes mellitus 9.1 VTN TNF TLR2 TF CXCL8
576 macular degeneration, age-related, 1 9.0 VTN TNF TLR2 CXCL8 CFH
577 inflammatory bowel disease 9.0 TNF TLR2 LTF CXCL8 CLEC7A
578 malaria 8.8 TNF TLR2 LTF CXCL8 CFH

Graphical network of the top 20 diseases related to Haemophilus Influenzae:



Diseases related to Haemophilus Influenzae

Symptoms & Phenotypes for Haemophilus Influenzae

MGI Mouse Phenotypes related to Haemophilus Influenzae:

45 (showing 1, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 homeostasis/metabolism MP:0005376 9.28 CFH CLEC7A LACTB LTF OMP TF

Drugs & Therapeutics for Haemophilus Influenzae

Drugs for Haemophilus Influenzae (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 150, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Temocillin Approved, Investigational Phase 4 66148-78-5
2
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
3
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
4
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
5 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
6
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
7
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
8
Ceftriaxone Approved Phase 4 73384-59-5 5361919 5479530
9 Strawberry Approved Phase 4
10
Olodaterol Approved Phase 4 868049-49-4
11
Budesonide Approved Phase 4 51333-22-3 63006 5281004
12
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
13 Chlorine dioxide Investigational Phase 4 10049-04-4
14 Anti-Inflammatory Agents Phase 4
15 Methylprednisolone Acetate Phase 4
16 Antineoplastic Agents, Hormonal Phase 4
17 Antitoxins Phase 4
18 Aluminum phosphate Phase 4
19 Chlorhexidine gluconate Phase 4
20 Anti-Infective Agents, Local Phase 4
21 Disinfectants Phase 4
22 Micronutrients Phase 4
23 Trace Elements Phase 4
24 Parasympatholytics Phase 4
25 Cholinergic Agents Phase 4
26 Tiotropium Bromide Phase 4 136310-93-5
27 Cholinergic Antagonists Phase 4
28 Adrenergic beta-Agonists Phase 4
29 Hormones Phase 4
30
Salmeterol xinafoate Phase 4 94749-08-3 56801
31 Adrenergic Agents Phase 4
32 Formoterol Fumarate Phase 4
33 Hormone Antagonists Phase 4
34 Fluticasone-Salmeterol Drug Combination Phase 4
35 glucocorticoids Phase 4
36 Anticonvulsants Phase 4
37 Sympathomimetics Phase 4
38 Bromides Phase 4
39 Neurotransmitter Agents Phase 4
40 Adrenergic Agonists Phase 4
41
Gemifloxacin Approved, Investigational Phase 3 175463-14-6 5464436 9571107
42
Rabeprazole Approved, Investigational Phase 3 117976-89-3 5029
43
Moxifloxacin Approved, Investigational Phase 3 354812-41-2, 151096-09-2 152946
44
tannic acid Approved Phase 3 1401-55-4
45
Benzocaine Approved, Investigational Phase 3 94-09-7, 1994-09-7 2337
46
Edetic Acid Approved, Vet_approved Phase 3 60-00-4, 62-33-9 6049
47
Iron Approved, Experimental Phase 3 15438-31-0, 7439-89-6 27284 23925
48
Pentetic acid Approved Phase 3 67-43-6
49
Deferiprone Approved Phase 3 30652-11-0 2972
50
Aluminum hydroxide Approved, Investigational Phase 3 21645-51-2
51
Lactitol Approved, Investigational Phase 3 585-88-6, 585-86-4 493591
52
Ceftaroline fosamil Approved, Investigational Phase 3 229016-73-3
53
leucovorin Approved Phase 3 58-05-9 6006 143
54
Ciprofloxacin Approved, Investigational Phase 3 85721-33-1 2764
55
Sulfamethoxazole Approved Phase 3 723-46-6 5329
56
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
57
Clarithromycin Approved Phase 3 81103-11-9 84029
58
Linezolid Approved, Investigational Phase 3 165800-03-3 441401
59
Acetaminophen Approved Phase 3 103-90-2 1983
60
Tobramycin Approved, Investigational Phase 3 32986-56-4 36294 5496
61
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
62 Fibrinolytic Agents Phase 3
63 Anticoagulants Phase 3
64 PENTA Phase 3
65 Norgestimate, ethinyl estradiol drug combination Phase 3
66 polysaccharide-K Phase 3
67 taxane Phase 3
68 Hemagglutinins Phase 3
69 Immunoglobulins, Intravenous Phase 3
70 Antidotes Phase 3
71 Chelating Agents Phase 3
72 Iron Chelating Agents Phase 3
73 Protective Agents Phase 3
74 Calcium, Dietary Phase 3
75 Lactams Phase 3
76 beta-Lactams Phase 3
77 Cytochrome P-450 Enzyme Inhibitors Phase 3
78 Fluoroquinolones Phase 3
79 Folic Acid Antagonists Phase 3
80 Vitamin B Complex Phase 3
81 Antiprotozoal Agents Phase 3
82 Folate Phase 3
83 Trimethoprim, Sulfamethoxazole Drug Combination Phase 3
84 Antiparasitic Agents Phase 3
85 Vitamin B9 Phase 3
86 Antimalarials Phase 3
87 Cytochrome P-450 CYP3A Inhibitors Phase 3
88 Adjuvants, Immunologic Phase 3
89 Broncho-Vaxom Phase 3
90 Analgesics, Non-Narcotic Phase 3
91 Analgesics Phase 3
92 Antipyretics Phase 3
93 Immunoglobulin E Phase 3
94
Calcium Nutraceutical Phase 3 7440-70-2 271
95
Streptomycin Approved, Vet_approved Phase 1, Phase 2 57-92-1 19649
96
Neomycin Approved, Vet_approved Phase 1, Phase 2 1404-04-2 8378
97
Aluminum sulfate Approved Phase 1, Phase 2 10043-01-3
98
Ibuprofen Approved Phase 2 15687-27-1 3672
99
Levofloxacin Approved, Investigational Phase 2 100986-85-4 149096
100
Ofloxacin Approved Phase 2 82419-36-1 4583
101
Azithromycin Approved Phase 2 83905-01-5 447043 55185
102
Fluticasone Approved, Experimental Phase 2 90566-53-3 62924
103 Angiogenesis Inhibitors Phase 2
104 Interleukin-12 Phase 2
105 Antacids Phase 1, Phase 2
106 Anti-Ulcer Agents Phase 1, Phase 2
107 Gastrointestinal Agents Phase 1, Phase 2
108 Cyclooxygenase Inhibitors Phase 2
109 Antirheumatic Agents Phase 2
110 Anti-Inflammatory Agents, Non-Steroidal Phase 2
111 Anti-Bacterial Agents Phase 2
112 Antibiotics, Antitubercular Phase 2
113 Anti-Infective Agents Phase 2
114 Respiratory System Agents Phase 2
115 Anti-Allergic Agents Phase 2
116 Anti-Asthmatic Agents Phase 2
117 Dermatologic Agents Phase 2
118 Bronchodilator Agents Phase 2
119
Histidine Investigational, Nutraceutical Phase 2 71-00-1 6274
120
Daptomycin Approved, Investigational Phase 1 103060-53-3 16129629
121
Hydroxocobalamin Approved 13422-51-0 15589840 11953898
122
Proguanil Approved 500-92-5 4923
123
Zinc Approved, Investigational 7440-66-6 32051
124
Penicillin V Approved, Vet_approved 87-08-1 6869
125
Zinc sulfate Approved, Investigational 7733-02-0
126
Hydroxyurea Approved 127-07-1 3657
127
Ertapenem Approved, Investigational 153832-46-3 150610
128
Clavulanate Approved, Vet_approved 58001-44-8 5280980
129
Amoxicillin Approved, Vet_approved 26787-78-0 33613
130
Cyanocobalamin Approved, Nutraceutical 68-19-9 44176380
131
Vitamin A Approved, Nutraceutical, Vet_approved 22737-96-8, 68-26-8, 11103-57-4 9904001